David C. Goldberg

2014 - Enzo Biochem

In 2014, David C. Goldberg earned a total compensation of $296.8K as Vice President Corporate Development and Interim General Manager, Enzo Clinical Labs at Enzo Biochem, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$20,000
Option Awards$32,342
Salary$215,000
Other$29,460
Total$296,802

Goldberg received $215K in salary, accounting for 72% of the total pay in 2014.

Goldberg also received $20K in non-equity incentive plan, $32.3K in option awards and $29.5K in other compensation.

Rankings

In 2014, David C. Goldberg's compensation ranked 11,759th out of 13,032 executives tracked by ExecPay. In other words, Goldberg earned more than 9.8% of executives.

ClassificationRankingPercentile
All
11,759
out of 13,032
10th
Division
Services
1,889
out of 2,087
10th
Major group
Health Services
209
out of 219
5th
Industry group
Medical And Dental Laboratories
50
out of 56
11th
Industry
Medical Laboratories
50
out of 56
11th
Source: SEC filing on November 26, 2014.

Goldberg's colleagues

We found five more compensation records of executives who worked with David C. Goldberg at Enzo Biochem in 2014.

2014

Elazar Rabbani

Enzo Biochem

Chief Executive Officer

2014

Barry Weiner

Enzo Biochem

Chief Financial Officer

2014

Andrew Crescenzo

Enzo Biochem

Senior Vice President of Finance

2014

Andrew Whiteley

Enzo Biochem

Chief Operating Officer

2014

James Brien

Enzo Biochem

Senior Vice President of Finance

News

You may also like